DrugPatentWatch Database Preview

PANTOPRAZOLE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Pantoprazole Sodium, and when can generic versions of Pantoprazole Sodium launch?

Pantoprazole Sodium is a drug marketed by Sun Pharm, Akorn Inc, Aurobindo Pharma Ltd, Mylan Labs Ltd, Sandoz Inc, Hikma, Actavis Totowa, Amneal Pharms, Atlantide, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Ingenus Pharms Llc, Jubilant Generics, L Perrigo Co, Lannett Co Inc, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Rubicon, Sun Pharm Inds Ltd, Teva, and Torrent Pharms. and is included in twenty-five NDAs.

The generic ingredient in PANTOPRAZOLE SODIUM is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pantoprazole Sodium

A generic version of PANTOPRAZOLE SODIUM was approved as pantoprazole sodium by ATLANTIDE on January 19^th, 2011.

Summary for PANTOPRAZOLE SODIUM

US Patents:	0
Applicants:	22
NDAs:	25
Finished Product Suppliers / Packagers:	50
Raw Ingredient (Bulk) Api Vendors:	55
Clinical Trials:	22
Patent Applications:	3,165
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PANTOPRAZOLE SODIUM
Drug Sales Revenues:	Drug sales revenues for PANTOPRAZOLE SODIUM
What excipients (inactive ingredients) are in PANTOPRAZOLE SODIUM?	PANTOPRAZOLE SODIUM excipients list
DailyMed Link:	PANTOPRAZOLE SODIUM at DailyMed

See drug prices for PANTOPRAZOLE SODIUM

See drug sales revenues for PANTOPRAZOLE SODIUM

Recent Clinical Trials for PANTOPRAZOLE SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mansoura University	N/A
Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4
Federal University of São Paulo	Phase 4

See all PANTOPRAZOLE SODIUM clinical trials

Pharmacology for PANTOPRAZOLE SODIUM

Drug Class	Proton Pump Inhibitor
Mechanism of Action	Proton Pump Inhibitors

Paragraph IV (Patent) Challenges for PANTOPRAZOLE SODIUM

Tradename	Dosage	Ingredient	NDA	Submissiondate
PROTONIX IV	INJECTABLE;IV (INFUSION)	pantoprazole sodium	020988	2005-04-07
PROTONIX	TABLET, DELAYED RELEASE;ORAL	pantoprazole sodium	020987	2004-02-02
PROTONIX	FOR SUSPENSION, DELAYED RELEASE;ORAL	pantoprazole sodium	022020

US Patents and Regulatory Information for PANTOPRAZOLE SODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Torrent Pharms	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090074-002	Jan 19, 2011	AB	RX	No	No
Rubicon	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090807-001	May 2, 2012	AB	RX	No	No
Mylan Pharms Inc	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090970-001	Jan 19, 2011	AB	RX	No	No
Rubicon	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090807-002	May 2, 2012	AB	RX	No	No
Mylan Pharms Inc	PANTOPRAZOLE SODIUM	pantoprazole sodium	TABLET, DELAYED RELEASE;ORAL	090970-002	Jan 19, 2011	AB	RX	No	No
Sun Pharm	PANTOPRAZOLE SODIUM	pantoprazole sodium	FOR SUSPENSION, DELAYED RELEASE;ORAL	213725-001	Jun 30, 2020	AB	RX	No	No